SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-032683
Filing Date
2013-06-04
Accepted
2013-06-04 20:02:45
Documents
1
Period of Report
2013-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 - MATT FOEHR 6-3-2013 rrd382315.html 4  
1 FORM 4 - MATT FOEHR 6-3-2013 rrd382315.xml 4 3272
  Complete submission text file 0001181431-13-032683.txt   4670
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11085 NORTH TORREY PINES RD #300 LA JOLLA CA 92037
Business Address
FOEHR MATTHEW W (Reporting) CIK: 0001237556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 13892919